NCT07436754

Brief Summary

The purpose of the study is to test two different training programs to find out which is better at helping people with a concussion or mild TBI (mTBI) improve their emotional health and well-being. Study participation is completely remote and will last approximately 8 months total, involving 4 assessment visits and 8 sessions of brain training via a secure video-conferencing platform. The 4 assessment visits (about 30-90 minutes each) include surveys and questionnaires about participant's emotional health. These assessment visits will take place before the training, immediately after the training, 3 months after training and 6 months after training. The 8 sessions of 1-on-1 training (about 60-90 minutes each) will be completed over the course of approximately 1 month.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
58mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

May 20, 2026

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2031

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2031

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

4.8 years

First QC Date

February 19, 2026

Last Update Submit

May 20, 2026

Conditions

Keywords

Emotional dysregulationBrain trainingConcussionVeteransMilitary service members

Outcome Measures

Primary Outcomes (2)

  • Toronto Alexithymia Scale-20

    his widely used alexithymia assessment (including the TBI population), is comprised of 3 factors: 1) ability to identify emotions); 2) ability to describe emotions; and 3) externally-oriented thinking. In addition to being a co-primary outcome measure, the TAS-20 scores will be used to determine eligibility (\>.5 SD above published means). It is a CDE and a PhenX toolkit measure has good psychometric properties, including good test-retest reliability. Range: Min/ Max = 20 to 100 Lower scores indicate less alexithymia (good); higher scores indicate greater alexithymia (bad)

    1) baseline 2) immediate post-treatment, 3) 3 months post-treatment; 4) 6- months post-treatment.

  • Difficulty with Emotion Regulation Scale (DERS; Co-Primary outcome)

    This commonly used measure of emotion dysregulation, uses a 5-point Likert scale, participants rate the frequency they utilize self-regulation behaviors in response to general emotional distress. Items are summed to provide a Total Emotion Dysregulation score. The DERS has high internal consistency, test-retest reliability, and good construct validity.56 Will be used to evaluate emotion dysregulation and to determine eligibility (\>.5 SD above published means). Range: Min/ Max = 36 to 180. Lower scores indicate less dysregulation (good); higher scores indicate more dysregulation (bad)

    1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

Secondary Outcomes (6)

  • Brief Resilience Scale (BRS)

    1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

  • Patient Health Questionnaire-9 (PHQ-9; depression)

    1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

  • PROMIS item banks for Anxiety

    1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

  • PROMIS item banks Anger

    1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

  • Post-traumatic Stress Checklist- 5 (PCL-5)

    1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months

  • +1 more secondary outcomes

Study Arms (2)

Program 1

EXPERIMENTAL

Enhance emotional awareness and ability to name, describe and express emotions with greater clarity, granularity and accuracy. Goals include enhancing participants' ability to: recognize and embrace the benefits of emotional awareness; detect onset of emotional responses early before escalation; accurately label and differentiate emotions; discern emotions from non-emotions; recognize and experience a larger breadth of emotions, including pleasant emotions.

Behavioral: Program 1

Program 2

ACTIVE COMPARATOR

To promote general wellbeing and quality of life. Grounded in Health Belief Model emphasizing self-management and self-efficacy. Content includes topics relevant to living health with a TBI Contents were derived from the Traumatic Brain Injury Model Systems Knowledge Translation Center factsheets and topics recommended by the Consumer advisory panel.

Behavioral: Program 2

Interventions

Program 1BEHAVIORAL

Program 1 will teach participants how to recognize, label, and differentiate their emotions. The program will cover ways to reduce feeling "confused" or numb, and decrease the feelings of anger, stress and being overwhelmed.

Program 1
Program 2BEHAVIORAL

Program 2 will teach participants strategies to improve their overall brain health and functioning. It will also teach participants how to develop and work towards individualized short-term and long-term goals aimed at improving their quality of life.

Program 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mild TBI
  • ≥18 years old
  • ≥6 months post-TBI
  • Elevated alexithymia and emotion dysregulation
  • Capacity to consent
  • Speaks and understands English
  • Personal device capable of video conferencing and internet

You may not qualify if:

  • Premorbid neurological disorder other than TBI
  • Degenerative neurologic condition
  • Active or uncontrolled major psychiatric disorder
  • Conditions that pose safety concern to self or others, such as suicide risk
  • Visual, hearing, communication, or cognitive impairments that would impede participation
  • Unstable medications (e.g., started \< 6 weeks prior to enrollment) or anticipated medication changes that will influence mood/ affect during study participation
  • Active involvement in an intensive rehabilitation program
  • Individuals who recently started psychotherapy and/or mental health counseling (e.g., \<3 months prior)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Indiana University

Indianapolis, Indiana, 46202, United States

NOT YET RECRUITING

National Intrepid Center Of Excellence

Bethesda, Maryland, 20889, United States

NOT YET RECRUITING

Hackensack Meridian Health - JFK Johnson Rehabilitation Institute

Edison, New Jersey, 08820, United States

RECRUITING

MeSH Terms

Conditions

Brain ConcussionAffective Symptoms

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, NonpenetratingBehavioral SymptomsBehavior

Study Officials

  • Dawn Neumann, PhD, FACRM

    Hackensack Meridian Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2026

First Posted

February 27, 2026

Study Start

May 20, 2026

Primary Completion (Estimated)

March 1, 2031

Study Completion (Estimated)

March 1, 2031

Last Updated

May 22, 2026

Record last verified: 2026-05

Locations